Biotechnology startup Clensta, grooming products retailer LetShave and healthtech firm Medimetry have raised funds, while Sequoia-backed HealthKart is looking to raise around $10 million.
Indian Angel Network backs biotech firm Clensta
Delhi-based biotechnology startup Clensta International, has raised an undisclosed amount of seed funding from Indian Angel Network and its maiden VC Fund, IAN Fund. The funding was led by IAN members – Rishabh Mehta, Founder & CEO LOCAD., Pradeep Gupta, Co-Founder IAN, Anirudh Agarwal and Sajiv Dhawan. According to an official statement, the investment will assist Clensta, which currently operates in the B2B space, to launch its products in the B2C space and develop newer products in the personal hygiene category.
Korea’s Dorco picks up 10% stake in LetsShave
Korean razor company Dorco Ltd made its first investment in India by acquiring 10 per cent stake in Ahmedabad-based grooming startup LetsShave. The company plans to use its Series A round of funding towards its online business and to expand its product portfolio to cater to men’s and women’s grooming needs more efficiently.
Healthtech startup Medimetry gets funding from BlueSky Capital
Healthtech startup Medimetry has raised seed funding of an undisclosed amount from US-based hedge fund BlueSky Capital Management, according to a VCCircle report. Two angel investors also participated in the round which will be used for sales, marketing and to upgrade its digital disease management platform. Medimetry offers an online platform for telemedicine, electronic medical records and disease management.
HealthKart looks to raise $10m in fresh funding round
Gurgaon-based health products retailer HealthKart, operated by Bright Lifecare Pvt. Ltd, is raising around $10 million in a fresh funding round from new and existing investors, said a VCCircle report quoting sources. As per the report, HealthKart’s existing backer Sequoia India will lead with a majority investment of around $6 million. IIFL Alternate Asset Advisors Ltd and another undisclosed investor are also likely to participate in the round, the report said.